# Safety of Injection of Placental Mesenchymal Stem Cell Derived Exosomes for Treatment of Resistant Perianal Fistula in Crohn's Patients

> **NCT05499156** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Tehran University of Medical Sciences** · enrollment: 80 (actual)

## Conditions studied

- Perianal Fistula in Patients With Crohn's Disease

## Interventions

- **OTHER:** placenal MSC derived exosomes

## Key facts

- **NCT ID:** NCT05499156
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-20
- **Primary completion:** 2022-08
- **Final completion:** 2022-09
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2022-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05499156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05499156, "Safety of Injection of Placental Mesenchymal Stem Cell Derived Exosomes for Treatment of Resistant Perianal Fistula in Crohn's Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05499156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*